AUSTIN, Texas — September 30, 2025 — Leads & Copy — EDAP TMS SA (Nasdaq: EDAP) announced its Focal One Robotic HIFU treatment was featured on national television on Friday, September 26, reaching millions as part of its Prostate Cancer Awareness Month campaign. The segment, featuring a patient treated with Focal One, aired on Health Uncensored with Dr. Drew on the Lifetime Network, providing national exposure. The company also hosted patient education events and partnered with hospitals to educate local communities.
During the interview, prostate cancer patient Peter D. shared his journey to selecting Focal One Robotic HIFU, explaining how he achieved his cancer treatment goals with minimal disruption to his daily life. Urologist Eric Giesler, MD, from Urology Austin, highlighted Focal One’s role in prostate cancer management.
Dr. Giesler commented on patients seeking effective treatments without impacting their quality of life, noting Focal One Robotic HIFU’s precision targeting of cancer while avoiding radical treatment complications. CEO Ryan Rhodes thanked Peter for sharing his story and noted the significance of the exposure in raising awareness among patients, caregivers, physicians, and the public.
The full interview is available at https://focalone.com/prostatetreatment/.
EDAP TMS develops, manufactures, promotes, and distributes minimally invasive medical devices using ultrasound technology. EDAP introduced the Focal One in Europe and the U.S. as a leading prostate focal therapy.
Contact:
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com
Source: EDAP TMS SA
